DK1180519T3 - Hydrochlorid af en kondenseret heterocyklisk forbindelse - Google Patents

Hydrochlorid af en kondenseret heterocyklisk forbindelse

Info

Publication number
DK1180519T3
DK1180519T3 DK00931547T DK00931547T DK1180519T3 DK 1180519 T3 DK1180519 T3 DK 1180519T3 DK 00931547 T DK00931547 T DK 00931547T DK 00931547 T DK00931547 T DK 00931547T DK 1180519 T3 DK1180519 T3 DK 1180519T3
Authority
DK
Denmark
Prior art keywords
hydrochloride
heterocyclic compound
condensed heterocyclic
compound
benzylüthiazolid
Prior art date
Application number
DK00931547T
Other languages
Danish (da)
English (en)
Inventor
Toshihiko Fujiwara
Takashi Fujita
Takashi Izumi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15340495&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1180519(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of DK1180519T3 publication Critical patent/DK1180519T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK00931547T 1999-05-24 2000-05-24 Hydrochlorid af en kondenseret heterocyklisk forbindelse DK1180519T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14351399 1999-05-24
PCT/JP2000/003325 WO2000071540A1 (fr) 1999-05-24 2000-05-24 Chlorhydrate de compose heterocyclique fusionne

Publications (1)

Publication Number Publication Date
DK1180519T3 true DK1180519T3 (da) 2005-06-13

Family

ID=15340495

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00931547T DK1180519T3 (da) 1999-05-24 2000-05-24 Hydrochlorid af en kondenseret heterocyklisk forbindelse

Country Status (25)

Country Link
US (1) US6706746B2 (zh)
EP (1) EP1180519B1 (zh)
KR (2) KR100748053B1 (zh)
CN (1) CN1156473C (zh)
AT (1) ATE294799T1 (zh)
AU (1) AU763731B2 (zh)
BR (1) BR0010914A (zh)
CA (1) CA2375017C (zh)
CZ (1) CZ297927B6 (zh)
DE (1) DE60019919T2 (zh)
DK (1) DK1180519T3 (zh)
ES (1) ES2240099T3 (zh)
HK (1) HK1042087B (zh)
HU (1) HU229340B1 (zh)
IL (1) IL146568A0 (zh)
MX (1) MXPA01012044A (zh)
NO (1) NO321578B1 (zh)
NZ (1) NZ515570A (zh)
PL (1) PL209389B1 (zh)
PT (1) PT1180519E (zh)
RU (1) RU2214410C2 (zh)
TR (1) TR200103353T2 (zh)
TW (1) TWI284533B (zh)
WO (1) WO2000071540A1 (zh)
ZA (1) ZA200109576B (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
WO2002051441A1 (fr) 2000-12-26 2002-07-04 Sankyo Company, Limited Compositions medicinales contenant un diuretique et un agent renforçant la resistance a l'insuline
US6756399B2 (en) * 2001-06-29 2004-06-29 The United States Of America As Represented By The Department Of Health And Human Services Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents
WO2003082865A1 (fr) * 2002-04-01 2003-10-09 Sankyo Company, Limited Composition médicinale antitumorale
AU2003254795A1 (en) * 2002-08-02 2004-02-23 Sankyo Company, Limited Resorcinol derivative
US6794401B2 (en) * 2003-01-17 2004-09-21 Bexel Pharmaceuticals, Inc. Amino acid phenoxy ethers
US7781464B2 (en) * 2003-01-17 2010-08-24 Bexel Pharmaceuticals, Inc. Heterocyclic diphenyl ethers
US7521465B2 (en) * 2003-01-17 2009-04-21 Bexel Pharmaceuticals, Inc. Diphenyl ether derivatives
JPWO2004106542A1 (ja) 2003-05-29 2006-07-20 三共株式会社 インスリン抵抗性改善剤及びそのスクリーニング方法
US7087576B2 (en) * 2003-10-07 2006-08-08 Bexel Pharmaceuticals, Inc. Dipeptide phenyl ethers
KR101154175B1 (ko) * 2003-10-24 2012-06-14 산텐 세이야꾸 가부시키가이샤 각결막 장해 치료제
EP1566202A1 (en) * 2004-02-23 2005-08-24 Sahltech I Göteborg AB Use of resistin antagonists in the treatment of rheumatoid arthritis
WO2005092382A1 (ja) * 2004-03-29 2005-10-06 Sankyo Company, Limited インスリン抵抗性改善剤を含有する糖尿病治療剤
TW200608967A (en) 2004-07-29 2006-03-16 Sankyo Co Pharmaceutical compositions containing with diabetic agent
EP1857118A1 (en) * 2004-12-13 2007-11-21 Daiichi Sankyo Company, Limited Medicinal composition for treating diabetes
TW200633702A (en) * 2004-12-15 2006-10-01 Sankyo Co Medicinal composition containing fbpase inhibitor
TW200637856A (en) * 2005-01-24 2006-11-01 Sankyo Co Process for producing thiazolidinedion compound and intermediate thereof
EP1889618A4 (en) * 2005-05-27 2010-11-24 Daiichi Sankyo Co Ltd COMBINED MEDICINE FOR THE TREATMENT OF DIABETES
WO2007007656A1 (ja) * 2005-07-08 2007-01-18 Daiichi Sankyo Company, Limited チアゾリジンジオン化合物を含有する医薬組成物
TW200738266A (en) * 2005-09-29 2007-10-16 Sankyo Co Pharmaceutical agent containing insulin resistance improving agent
KR101409705B1 (ko) 2005-11-28 2014-07-14 센주 세이야꾸 가부시키가이샤 Ｐｐａｒ 아고니스트 함유 의약
AU2008239179B2 (en) * 2007-04-05 2011-02-24 Daiichi Sankyo Company, Limited Fused bicyclic heteroaryl derivatives
MX2009012600A (es) 2007-05-21 2010-03-15 Senju Pharma Co Farmaceutico que contiene el agonista ppar alfa.
US8722710B2 (en) 2007-09-26 2014-05-13 Deuterx, Llc Deuterium-enriched pioglitazone
JPWO2010101164A1 (ja) 2009-03-05 2012-09-10 第一三共株式会社 ピリジン誘導体
US8969581B2 (en) 2013-03-14 2015-03-03 Deuterx, Llc 5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same
US10188639B2 (en) 2014-01-15 2019-01-29 Deuterx, Llc Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
US11319313B2 (en) 2020-06-30 2022-05-03 Poxel Sa Crystalline forms of deuterium-enriched pioglitazone
US11767317B1 (en) 2020-06-30 2023-09-26 Poxel Sa Methods of synthesizing enantiopure deuterium-enriched pioglitazone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ293016B6 (cs) 1995-06-01 2004-01-14 Sankyo Company Limited Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem
US5798375A (en) 1995-07-03 1998-08-25 Sankyo Company, Limited Treatment of arteriosclerosis and xanthoma
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
AU760917B2 (en) * 1999-07-19 2003-05-22 Sankyo Company Limited Preventive and therapeutic agents for cancer

Also Published As

Publication number Publication date
ZA200109576B (en) 2003-02-20
KR20070034112A (ko) 2007-03-27
CA2375017A1 (en) 2000-11-30
CZ297927B6 (cs) 2007-05-02
US20020111373A1 (en) 2002-08-15
RU2214410C2 (ru) 2003-10-20
TWI284533B (en) 2007-08-01
KR100748053B1 (ko) 2007-08-09
HU229340B1 (en) 2013-11-28
ES2240099T3 (es) 2005-10-16
BR0010914A (pt) 2002-02-19
EP1180519A4 (en) 2002-07-10
DE60019919T2 (de) 2006-02-16
EP1180519A1 (en) 2002-02-20
US6706746B2 (en) 2004-03-16
HK1042087A1 (en) 2002-08-02
NZ515570A (en) 2003-11-28
NO20015712L (no) 2001-12-20
HUP0201334A2 (en) 2002-10-28
IL146568A0 (en) 2002-07-25
CN1156473C (zh) 2004-07-07
NO20015712D0 (no) 2001-11-23
PL351650A1 (en) 2003-05-19
EP1180519B1 (en) 2005-05-04
WO2000071540A1 (fr) 2000-11-30
KR20010113972A (ko) 2001-12-28
HK1042087B (zh) 2005-09-09
HUP0201334A3 (en) 2002-11-28
NO321578B1 (no) 2006-06-06
ATE294799T1 (de) 2005-05-15
CA2375017C (en) 2009-05-19
PL209389B1 (pl) 2011-08-31
DE60019919D1 (de) 2005-06-09
PT1180519E (pt) 2005-06-30
CZ20014182A3 (cs) 2002-04-17
AU763731B2 (en) 2003-07-31
KR100783348B1 (ko) 2007-12-07
MXPA01012044A (es) 2002-05-06
AU4948700A (en) 2000-12-12
CN1364168A (zh) 2002-08-14
TR200103353T2 (tr) 2002-04-22

Similar Documents

Publication Publication Date Title
DK1180519T3 (da) Hydrochlorid af en kondenseret heterocyklisk forbindelse
DE69803907D1 (de) Fungizide 2-Methoxybenzophenone
EA200200661A1 (ru) 3-аминохиназолин-2,4-дионовые антибактериальные агенты
DK1131315T3 (da) Polyhydroxylerede heterocykliske derivater som antikoagulanter
DE60229736D1 (de) Spiroinden- und spiroindan-verbindungen
DE60214392D1 (de) 1,4-disubstituierte benzokondensierte cycloalkyl harnstoffverbindungen
ATE360617T1 (de) Benzoheterocyclische verbindungen verwendbar als vasopressin- oder oxytocin-modulatoren
ATE403429T1 (de) Spiropyrazol-verbindungen
NO20024766D0 (no) Etyldiaminderivater
WO2005105096A3 (en) Fused heterocyclic compounds
DK1385518T3 (da) Benzimidazolon-forbindelser
DE60014143D1 (de) Antimikrobielle 4-oxochinolizine mit 2-pyridongerüsten als teilstruktur
EP1460057A4 (en) PERFLUORADAMANTYLACRYLATE COMPOUND AND INTERMEDIATE PRODUCTS THEREFOR
EA200300706A1 (ru) Замещенные 8-арилхинолины в качестве ингибиторов фосфодиэстеразы-4
EA200000016A1 (ru) Гидроксициклопентанон
NO974588D0 (no) Triazol-antifungaltmiddel
BR9902096A (pt) Pitazóis.
DE60039695D1 (de) Antifucoidan antikörper
DK1433480T3 (da) Lægemiddel indeholdende pyrimidin-derivat
EP1557407A4 (en) NEW ALPHA-CETOAMIDE DERIVATIVE AND USE THEREOF
DE60322856D1 (zh)
ITMI20010283V0 (it) Porta ad impacchettamento rapido, ad elevata semplicita' di assemblaggio.
TH64452A (th) อนุพันธ์ของฮาโลจีเนเตต 2-อะมิโน-5,6-เฮปทีโนอิก แอซิดที่เป็นประโยชน์ในฐานะตัวยับยั้ง ไนตริก ออกไซด์ ซินเธส